Dudediligence.

Prelude Therapeutics Incorporated

PRLDNASDAQ · Pharmaceutical Preparations
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$3.0MSep ’24$4.0MDec ’24$0.00Mar ’25$6.5MSep ’25$5.6MDec ’25$4.6MMar ’26$5.7MJun ’26
Net income, by quarter
−$32.3MSep ’24−$28.7MDec ’24−$32.1MMar ’25−$31.2MJun ’25−$19.7MSep ’25−$16.5MDec ’25−$10.4MMar ’26−$13.9MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenuenone on filenone on filenone on file$7.0M$12.1M
Operating income−$113.7M−$123.5M−$132.3M−$139.7M−$104.6M
Net income−$111.7M−$115.4M−$121.8M−$127.2M−$99.5M
Operating cash flow−$83.5M−$83.7M−$107.1M−$102.9M−$56.3M
Free cash flow−$85.9M−$86.7M−$110.6M−$103.7M−$56.4M
Cash$31.8M$30.6M$25.3M$12.5M$35.3M
Shares outstanding46.0M47.4M60.4M75.8M77.0M